Fusion Pharmaceuticals CEO John Valliant's 2022 pay slips 16% to $2.7M

Fusion Pharmaceuticals reports 2022 executive compensation

By ExecPay News

Published: April 27, 2023

Fusion Pharmaceuticals reported fiscal year 2022 executive compensation information on April 27, 2023.
In 2022, three executives at Fusion Pharmaceuticals received on average a compensation package of $1.9M, a 29% decrease compared to previous year.
Average pay of disclosed executives at Fusion Pharmaceuticals
John Valliant, Chief Executive Officer, received $2.7M in total, which decreased by 16% compared to 2021. 69% of Valliant's compensation, or $1.9M, was in option awards. Valliant also received $238K in non-equity incentive plan, $595K in salary, as well as $31K in other compensation.
John Crowley, Chief Financial Officer, received a compensation package of $1.4M, which decreased by 11% compared to previous year. 54% of the compensation package, or $773K, was in option awards.
Eric Burak, Chief Technology Officer, earned $1.4M in 2022, a 52% decrease compared to previous year.

Related executives

John Valliant

Fusion Pharmaceuticals

Chief Executive Officer

Eric Burak

Fusion Pharmaceuticals

Chief Technology Officer

John Crowley

Fusion Pharmaceuticals

Chief Financial Officer

You may also like

Source: SEC filing on April 27, 2023.